Nicorandil can lead to anal ulceration. This is because ulceration is a known side effect of nicorandil, which can cause ulcers in the skin, mucosa, and eyes. It can also cause gastrointestinal ulcers that may result in complications such as perforation, haemorrhage, fistula, or abscess. If ulceration occurs, nicorandil treatment should be discontinued, and alternative medication should be considered.

Nicorandil is a medication that is commonly used to treat angina. It works by activating potassium channels, which leads to vasodilation. This process is achieved through the activation of guanylyl cyclase, which results in an increase in cGMP. However, there are some adverse effects associated with the use of nicorandil, including headaches, flushing, and the development of ulcers on the skin, mucous membranes, and eyes. Additionally, gastrointestinal ulcers, including anal ulceration, may also occur. It is important to note that nicorandil should not be used in patients with left ventricular failure.

The symptoms exhibited by the patient suggest acute hepatitis, with fever and jaundice being prominent. Autoimmune hepatitis is typically observed in young females, making it less likely in this male patient. Hence, hepatitis A is a more probable diagnosis, given his presentation of myalgia, sore throat, fever, and jaundice.

Understanding Hepatitis A: Symptoms, Transmission, and Prevention

Hepatitis A is a viral infection that affects the liver. It is usually a mild illness that resolves on its own, with serious complications being rare. The virus is transmitted through the faecal-oral route, often in institutions. The incubation period is typically 2-4 weeks, and symptoms include a flu-like prodrome, abdominal pain (usually in the right upper quadrant), tender hepatomegaly, jaundice, and deranged liver function tests.

While complications are rare, there is no increased risk of hepatocellular cancer. An effective vaccine is available, and it is recommended for people travelling to or residing in areas of high or intermediate prevalence, those with chronic liver disease, patients with haemophilia, men who have sex with men, injecting drug users, and individuals at occupational risk (such as laboratory workers, staff of large residential institutions, sewage workers, and people who work with primates).

It is important to note that the vaccine requires a booster dose 6-12 months after the initial dose. By understanding the symptoms, transmission, and prevention of hepatitis A, individuals can take steps to protect themselves and others from this viral infection.

Initial Management for Suspected Pancreatic Cancer: Abdominal CT Scan

When a patient over 60 years old presents with weight loss and abdominal pain, an urgent direct-access CT scan should be considered to assess for pancreatic cancer. Other symptoms that may indicate pancreatic cancer include diarrhea, back pain, nausea, vomiting, constipation, and new-onset diabetes. Patients with pancreatic cancer typically report anorexia, malaise, fatigue, mid-epigastric or back pain, and weight loss. The pain may be unrelenting and worse when lying flat.

The most characteristic sign of pancreatic carcinoma of the head of the pancreas is painless obstructive jaundice. Migratory thrombophlebitis and venous thrombosis also occur with higher frequency in patients with pancreatic cancer and may be the first presentation.

While the CA 19-9 antigen is elevated in 75-80% of patients with pancreatic carcinoma, it is not recommended for screening. An abdominal ultrasound scan may reveal a pancreatic malignancy, but a CT scan is the preferred imaging that should be carried out urgently.

Direct-access upper GI endoscopy may be appropriate for patients over 55 years old with weight loss and upper abdominal pain, reflux, or dyspepsia. However, in this case, an urgent CT scan is the most appropriate initial investigation due to the elevated alkaline phosphatase suggesting biliary obstruction. Checking ferritin levels may not be helpful in ruling in or out pancreatic cancer.

Initial Management for Suspected Pancreatic Cancer: Abdominal CT Scan

Differentiating Anorectal Conditions: Ischiorectal Abscess, Rectocele, Inflamed Anal Skin Tag, Perianal Abscess, and Pilonidal Abscess

An ischiorectal abscess is a deeper and larger abscess that is further from the anus. It presents as a deep, tender swelling and may not have external signs until late. When it discharges, it does so through an external opening that is typically more than 5 cm from the anus.

A rectocele is a prolapse of the wall between the rectum and the vagina and is not usually painful. It is not present in male patients.

An anal skin tag is a fibro-epithelial polyp that hangs off the skin around the outside of the anus. It may become infected and inflamed, but it would not extend 12 cm from the anus.

A perianal abscess is a simple anorectal abscess that arises from glandular crypts in the anus or rectum. It presents as a red, tender swelling close to the anus.

A pilonidal abscess presents as a painful, tender lump in the natal cleft, which may be fluctuant and have a purulent discharge. It may also have accompanying cellulitis. However, the location described here is not consistent with a pilonidal abscess.

In summary, understanding the characteristics and locations of different anorectal conditions can aid in their differentiation and appropriate management.

Acute Pancreatitis: Causes and Risk Factors

Acute pancreatitis is a condition that can be caused by various factors. Certain drugs, such as azathioprine, can increase the risk of developing acute pancreatitis. Gallstones are also a common cause, and can be identified by the presence of Cullen’s sign (periumbilical darkening) or Gray-Turner’s sign (flank darkening). Infections like mumps and Coxsackie B can also lead to acute pancreatitis. Smoking and scorpion bites are other risk factors, with smoking having a synergistic effect when combined with high alcohol intake. Despite the various causes, most single acute episodes of pancreatitis result in uncomplicated recovery.

Elevated urea levels may suggest an upper GI bleed rather than a lower GI bleed. Iron deficiency anemia or anemia of chronic disease do not account for the increased urea. Chronic kidney disease would result in a corresponding increase in creatinine, in addition to the elevated urea. The raised urea is caused by the digestion of the substantial protein meal of blood in the upper GI tract, which would not occur in a lower GI bleed.

Acute upper gastrointestinal bleeding is a common and significant medical issue that can be caused by various conditions, with oesophageal varices and peptic ulcer disease being the most common. The main symptoms include haematemesis (vomiting of blood), melena (passage of altered blood per rectum), and a raised urea level due to the protein meal of the blood. The diagnosis can be determined by identifying the specific features associated with a particular condition, such as stigmata of chronic liver disease for oesophageal varices or abdominal pain for peptic ulcer disease.

The differential diagnosis for acute upper gastrointestinal bleeding includes oesophageal, gastric, and duodenal causes. Oesophageal varices may present with a large volume of fresh blood, while gastric ulcers may cause low volume bleeds that present as iron deficiency anaemia. Duodenal ulcers are usually posteriorly sited and may erode the gastroduodenal artery. Aorto-enteric fistula is a rare but important cause of major haemorrhage associated with high mortality in patients with previous abdominal aortic aneurysm surgery.

The management of acute upper gastrointestinal bleeding involves risk assessment using the Glasgow-Blatchford score, which helps clinicians decide whether patients can be managed as outpatients or not. Resuscitation involves ABC, wide-bore intravenous access, and platelet transfusion if actively bleeding platelet count is less than 50 x 10*9/litre. Endoscopy should be offered immediately after resuscitation in patients with a severe bleed, and all patients should have endoscopy within 24 hours. Treatment options include repeat endoscopy, interventional radiology, and surgery for non-variceal bleeding, while terlipressin and prophylactic antibiotics should be given to patients with variceal bleeding. Band ligation should be used for oesophageal varices, and injections of N-butyl-2-cyanoacrylate for patients with gastric varices. Transjugular intrahepatic portosystemic shunts (TIPS) should be offered if bleeding from varices is not controlled with the above measures.

Helicobacter Infection and Treatment

Helicobacter infection is common in patients with duodenal and peptic ulceration. The recommended therapy includes acid suppression and eradication of Helicobacter. Triple therapy with a proton pump inhibitor (PPI) such as omeprazole, along with two antibiotics (amoxicillin/clarithromycin plus metronidazole), has been found to be highly effective.

It is important to note that patients who are allergic to penicillin require a different treatment regimen. The lowest cost treatment option should be chosen, taking into account previous exposure to clarithromycin or metronidazole. In cases where the patient is allergic to penicillin and has had previous exposure to clarithromycin, bismuth and tetracycline should be added to the treatment regimen.

The recommended PPI doses for Helicobacter pylori eradication therapy are esomeprazole 20 mg, lansoprazole 30 mg, omeprazole 20-40 mg, pantoprazole 40 mg, and rabeprazole 20 mg. It is important to follow these guidelines to ensure effective treatment of Helicobacter infection.

The Role of Carcinoembryonic Antigen (CEA) in Cancer Management

Carcinoembryonic antigen (CEA) is a glycoprotein that is primarily produced by cells in the gastrointestinal tract during embryonic development. While its levels are low in adults, CEA is a useful tumour marker for colorectal cancers. In this article, we explore the different ways in which CEA is used in cancer management.

Postoperative Follow-up
CEA levels are expected to fall to normal following successful removal of colorectal cancer. A rising CEA level thereafter may indicate possible progression or recurrence of the cancer. However, temporary rises can occur during chemotherapy and radiotherapy, so changes during treatment may not necessarily indicate cancer progression.

Staging
CEA levels are not used in staging as there are many variables that can affect the levels. More reliable investigations are used for staging.

Indicator for Operability
While a CEA level at diagnosis higher than 100 ng/ml usually indicates metastatic disease, other investigations are used in the initial assessment of a newly diagnosed cancer to determine suitability for operative management.

Screening Method
CEA is not sensitive or specific enough to use for diagnosis or screening. Cancers of the pancreas, stomach, breast, lung, medullary carcinoma of the thyroid, and ovarian cancer may also elevate CEA. Some non-malignant conditions such as cirrhosis, pancreatitis, and inflammatory bowel disease also cause blood levels to rise.

Detection of Early Stage
CEA is not used for the diagnosis of colorectal cancers as it is not sufficiently sensitive or specific. Early tumours may not cause significant blood elevations, nor may some advanced tumours.

Medications for Maintaining Remission in Crohn’s Disease

Crohn’s disease is a chronic inflammatory condition that affects the digestive tract. While some patients may choose not to take medication to maintain remission, others may opt for drug therapy. The two main options are azathioprine and mercaptopurine, but it is important to measure thiopurine methyltransferase (TPMT) activity before using these drugs. Sulfasalazine is effective in maintaining remission for ulcerative colitis but has limited efficacy for Crohn’s disease. Methotrexate may be considered if other drugs fail or are not tolerated. Metronidazole is used for perianal disease but not for maintaining remission. Conventional corticosteroids like prednisolone or budesonide should not be used for long-term maintenance due to the risks associated with prolonged steroid use. Preventative treatment may be particularly appropriate for those with adverse prognostic factors such as early age of onset, perianal disease, corticosteroid use at presentation, and severe illness at presentation.

Acute pancreatitis is a condition that is primarily caused by gallstones and alcohol consumption in the UK. However, there are other factors that can contribute to the development of this condition. A popular mnemonic used to remember these factors is GET SMASHED, which stands for gallstones, ethanol, trauma, steroids, mumps, autoimmune diseases, scorpion venom, hypertriglyceridaemia, hyperchylomicronaemia, hypercalcaemia, hypothermia, ERCP, and certain drugs. It is important to note that pancreatitis is seven times more common in patients taking mesalazine than sulfasalazine. CT scans can show diffuse parenchymal enlargement with oedema and indistinct margins in patients with acute pancreatitis.

Importance of Stopping Acid Suppression Medication Prior to Endoscopy

In urgent cases where endoscopy is required, it is recommended to stop acid suppression medication for at least two weeks before the procedure. This is because acid suppression medication can hide serious underlying conditions that need to be addressed. However, there may be situations where stopping the medication is difficult due to symptoms, and clinical judgement must be used.

For instance, if a patient experiences unintentional weight loss, it is a red flag symptom for upper GI malignancy, and urgent referral for endoscopy is necessary. In such cases, the benefits of stopping acid suppression medication should be weighed against the potential risks of continuing it. Ultimately, the decision should be made based on the patient’s individual circumstances and the urgency of the situation. Proper evaluation and management can help ensure the best possible outcome for the patient.

Understanding Ulcerative Colitis

Ulcerative colitis is a type of inflammatory bowel disease that causes inflammation in the rectum and spreads continuously without going beyond the ileocaecal valve. It is most commonly seen in people aged 15-25 years and 55-65 years. The symptoms of ulcerative colitis are insidious and intermittent, including bloody diarrhea, urgency, tenesmus, abdominal pain, and extra-intestinal features. Diagnosis is done through colonoscopy and biopsy, but in severe cases, a flexible sigmoidoscopy is preferred to avoid the risk of perforation. The typical findings include red, raw mucosa that bleeds easily, widespread ulceration with preservation of adjacent mucosa, and inflammatory cell infiltrate in lamina propria. Extra-intestinal features of inflammatory bowel disease include arthritis, erythema nodosum, episcleritis, osteoporosis, uveitis, pyoderma gangrenosum, clubbing, and primary sclerosing cholangitis. Ulcerative colitis is linked with sacroiliitis, and a barium enema can show the whole colon affected by an irregular mucosa with loss of normal haustral markings.

Retesting for Helicobacter pylori after Eradication Therapy

The NICE guidelines on Dyspepsia (CG184) provide recommendations for retesting patients who have received eradication therapy for Helicobacter pylori. The first-line tests for detecting H. pylori are the stool antigen test and the urea breath test, while serological testing can be used if locally validated. However, serology is not appropriate for retesting as it remains positive due to past exposure. Saliva assays are inconsistent in accuracy, and gastric biopsy is invasive and costly.

If a patient tests positive for H. pylori and receives eradication therapy, retesting may be necessary. Currently, there is insufficient evidence to recommend stool antigen testing as a test of eradication. Therefore, NICE recommends retesting via the urea breath test.

First-line Testing for Coeliac Disease

The National Institute for Health and Care Excellence recommends that the first-line testing for coeliac disease should be for immunoglobulin A (IgA) anti-tissue transglutaminase, replacing IgA endomysial antibodies (EMA) as the most appropriate initial test. Total IgA is also typically measured. However, false negatives may occur if there is an IgA deficiency. In such cases, positive testing should prompt referral for biopsy. False-negative results may also occur in patients who have abstained from gluten for some time. Antigliadin antibodies are no longer used routinely due to their low specificity and sensitivity. Faecal fat is a nonspecific sign of malabsorption and can be positive in many other conditions, such as chronic pancreatitis, cystic fibrosis, and following gastrectomy.

Gastro-oesophageal Reflux and its Potential Consequences

The patient’s medical history indicates a prolonged period of gastro-oesophageal reflux, which can lead to the development of Barrett’s oesophagus. This condition occurs when the normal squamous epithelium of the oesophageal lining is replaced by columnar epithelium, which is a precursor to cancer. To monitor for the presence of metaplasia, surveillance endoscopies are recommended every two to five years, depending on the length of the Barrett’s segment. If dysplasia is detected, more frequent surveillance or treatment may be necessary.

The onset of dysphagia for solids and weight loss is concerning, as it may indicate the presence of oesophageal carcinoma.

The patient’s symptoms suggest a diagnosis of achalasia, which is characterized by the failure of the lower oesophageal sphincter to relax, leading to a functional stricture. This can cause substernal cramps, regurgitation, and pulmonary aspiration due to the retention of food and saliva in the oesophagus, resulting in a nocturnal cough. Diagnosis is made using a barium swallow, and treatment involves endoscopic balloon dilation or cardiomyotomy. Barrett’s oesophagus, motor neurone disease, oesophageal carcinoma, and pharyngeal pouch are less likely diagnoses based on the patient’s age, symptoms, and medical history.

Primary Sclerosing Cholangitis in Patients with Ulcerative Colitis

Patients with elevated ALP levels may be incidentally picked up and require further investigation. However, those who are symptomatic may present with jaundice, pruritus, fatigue, and abdominal pain. Clinically, patients may also have hepatomegaly and be jaundiced.

In the case of a patient with ulcerative colitis, the likelihood of primary sclerosing cholangitis (PSC) is significantly increased. Approximately 3% of UC sufferers have PSC, and 80% of those with PSC have UC. While gallstones in the common bile duct and liver cysts of hydatid disease can present with similar symptoms, the history of UC makes PSC a more likely diagnosis. Haemolytic anaemia and osteomalacia can cause elevated ALP levels, but they would not account for the cholestatic liver function and hepatomegaly seen in PSC.

Non-Alcoholic Fatty Liver Disease (NAFLD) and its Causes

Non-alcoholic fatty liver disease (NAFLD) is a common condition caused by the accumulation of fat in the liver, leading to inflammation. It is often associated with obesity, hypertension, dyslipidaemia, and insulin resistance. NAFLD is the most likely cause of liver enzyme abnormalities in patients with these conditions. However, other causes of hepatitis should be excluded before making this diagnosis.

Patients who are obese and diabetic are advised to lose weight and control their diabetes. A low-fat, low-calorie diet is usually recommended alongside treatment to lower HbA1c. Patients with NAFLD should avoid alcohol or other substances that could be harmful to the liver. It is important to note that deranged liver enzymes are not listed as side effects for amoxicillin in the British National Formulary.

Differential Diagnosis of Abnormal Liver Function Tests

Abnormal liver function tests can be caused by a variety of factors, including medication use. In this case, the patient displays a cholestatic picture with a rise in alkaline phosphatase and gamma-glutamyl transferase levels exceeding the rise in alanine aminotransferase levels. Here is a differential diagnosis of potential causes:

Erythromycin: This medication can cause cholestatic hepatotoxicity, which may have been used to treat the patient’s sore throat.

Digoxin: While digoxin is a potentially toxic drug, it doesn’t typically cause hepatotoxicity. Symptoms of digoxin toxicity may include arrhythmias, gastrointestinal disturbance, confusion, or yellow vision.

Methotrexate: Hepatotoxicity is a well-known side effect of methotrexate use, but it would be expected to see higher ALT levels in this case.

Paracetamol: Overdosing on paracetamol can cause hepatotoxicity, but it would typically present as hepatocellular damage with a predominant rise in transaminases.

Rosuvastatin: Statins may cause abnormalities in liver function tests, but cholestatic hepatotoxicity is rare and would not typically present with a disproportionate rise in transaminases.

In conclusion, the patient’s abnormal liver function tests may be attributed to erythromycin use, but further investigation is necessary to confirm the diagnosis.

Treatment Options for Irritable Bowel Syndrome (IBS)

When it comes to treating irritable bowel syndrome (IBS), there are several options available. The National Institute for Health and Care Excellence (NICE) recommends tricyclic antidepressants as a second-line treatment if other medications have not been effective. Treatment should start at a low dose and be reviewed regularly. Acupuncture and aloe vera are not recommended by NICE for the treatment of IBS. It is suggested to limit intake of high-fibre foods and increase intake of fresh fruit, but to limit it to three portions per day. It’s important to consult with a healthcare professional to determine the best treatment plan for individual needs.

Gastrointestinal Conditions and Their Associated Cancer Risks

Barrett’s Oesophagus, Duodenal Ulceration, Crohn’s Disease, Partial Gastrectomy, and Ulcerative Colitis are all gastrointestinal conditions that have been linked to an increased risk of cancer.

Barrett’s Oesophagus is a condition where the normal lining of the oesophagus is replaced by metaplastic columnar epithelium, which can lead to dysplasia and invasive adenocarcinoma. Risk factors for progression to adenocarcinoma include male sex, increasing age, extended segment disease, and family history. Smoking and alcohol are also strong risk factors.

Duodenal Ulceration is caused by Helicobacter pylori infection and has been linked to an increased risk of non-cardia gastric cancer.

Crohn’s Disease increases the risk of colon cancer, particularly if the entire colon is involved. The risk of small-intestinal malignancy is also increased.

Partial Gastrectomy is not associated with an increased risk of oesophageal adenocarcinoma, but gastric-stump cancer is a risk after partial gastrectomy, typically occurring ten years or longer after the procedure.

Ulcerative Colitis carries a significantly increased risk of colon cancer, with the extent and duration of the disease being important factors.

Overall, it is important for individuals with these gastrointestinal conditions to be aware of their increased cancer risk and to undergo regular screenings and surveillance to detect any potential malignancies early.

Caloric and Fat Content of Selected Foods

When it comes to watching our calorie and fat intake, it’s important to be mindful of the foods we consume. Here’s a breakdown of the caloric and fat content of some common foods:

Cheddar Cheese 100g
This amount of cheddar cheese contains a whopping 413 kcal and 34g of fat, making it the highest in both categories compared to the other foods listed.

Banana 100g
A 100g banana contains 95 kcal and is a great source of potassium and fiber.

Cornflakes 30g
A 30g serving of cornflakes with 125 ml of semi-skimmed milk contains 173 kcal and 2.5g of fat.

Orange Juice Unsweetened 140ml
140 ml of unsweetened orange juice contains roughly 50 kcal. While it’s important to be mindful of sugar intake, consuming a small glass of fruit juice each day can count towards our recommended daily intake of fruits and vegetables.

Plain Scone 48g
A plain scone weighing 48g contains around 173 kcal and 7g of fat. It’s important to enjoy treats in moderation and balance them with healthier options.

Smoking increases the likelihood of developing Crohn’s disease.

Experiencing infectious gastroenteritis raises the risk of developing Crohn’s disease by four times, especially within the first year.

The chances of developing Crohn’s disease are higher in the early stages after having an appendicectomy.

Crohn’s disease affects both genders equally, with no significant difference in occurrence rates.

Understanding Crohn’s Disease

Crohn’s disease is a type of inflammatory bowel disease that can affect any part of the digestive tract, from the mouth to the anus. The exact cause of Crohn’s disease is unknown, but there is a strong genetic component. Inflammation occurs in all layers of the affected area, which can lead to complications such as strictures, fistulas, and adhesions.

Symptoms of Crohn’s disease typically appear in late adolescence or early adulthood and can include nonspecific symptoms such as weight loss and lethargy, as well as more specific symptoms like diarrhea, abdominal pain, and perianal disease. Extra-intestinal features, such as arthritis, erythema nodosum, and osteoporosis, are also common in patients with Crohn’s disease.

To diagnose Crohn’s disease, doctors may look for raised inflammatory markers, increased faecal calprotectin, anemia, and low levels of vitamin B12 and vitamin D. It’s important to note that Crohn’s disease shares some features with ulcerative colitis, another type of inflammatory bowel disease, but there are also important differences between the two conditions. Understanding the symptoms and diagnostic criteria for Crohn’s disease can help patients and healthcare providers manage this chronic condition more effectively.

IBS patients should steer clear of insoluble sources of fiber like bran and wholemeal.

Managing irritable bowel syndrome (IBS) can be challenging and varies from patient to patient. The National Institute for Health and Care Excellence (NICE) updated its guidelines in 2015 to provide recommendations for the management of IBS. The first-line pharmacological treatment depends on the predominant symptom, with antispasmodic agents recommended for pain, laxatives (excluding lactulose) for constipation, and loperamide for diarrhea. If conventional laxatives are not effective for constipation, linaclotide may be considered. Low-dose tricyclic antidepressants are the second-line pharmacological treatment of choice. For patients who do not respond to pharmacological treatments, psychological interventions such as cognitive behavioral therapy, hypnotherapy, or psychological therapy may be considered. Complementary and alternative medicines such as acupuncture or reflexology are not recommended. General dietary advice includes having regular meals, drinking at least 8 cups of fluid per day, limiting tea and coffee to 3 cups per day, reducing alcohol and fizzy drink intake, limiting high-fiber and resistant starch foods, and increasing intake of oats and linseeds for wind and bloating.

NICE Guidelines for Urgent Referral and Faecal Occult Blood Testing in Patients with Change in Bowel Habit

In accordance with NICE guidelines, patients aged 60 years and older with a change in bowel habit towards looser and more frequent stools (without rectal bleeding) should be urgently referred. This applies to our 68-year-old male patient. While faecal occult blood testing is not necessary in this case, NICE offers guidance on whom to test for colorectal cancer using this method.

According to the guidelines, faecal occult blood testing should be offered to adults without rectal bleeding who are aged 50 and over with unexplained abdominal pain or weight loss. Additionally, those aged under 60 with changes in bowel habit or iron-deficiency anaemia should also be tested. For patients aged 60 and over, testing should be offered if they have anaemia even in the absence of iron deficiency.

It is important to follow these guidelines to ensure timely and appropriate management of patients with potential colorectal cancer.

Monash University in Australia has recently introduced a low-FODMAP diet for managing irritable bowel syndrome (IBS). FODMAPs are short-chain carbohydrates that are poorly absorbed in the small intestine, leading to water intake and diarrhea or fermentation by bacteria causing bloating in the large bowel. A low-FODMAP diet has been found to reduce IBS symptoms such as bloating, abdominal pain, and irregular bowel habits. However, it is a challenging diet to follow as it excludes many foods containing Oligo-, Di-, Mono-saccharides and Polyols, including wheat, dairy, pulses, excess fructose, and some vegetables. Therefore, it is recommended to seek the advice of a dietician.

The LOFFLEX diet, which stands for low fat/fibre exclusion diet, has been developed for individuals with Crohn’s disease. It is often used after the elemental diet to maintain remission by avoiding high-fiber and high-fat foods that can trigger Crohn’s. The ketogenic diet has been shown to improve seizure control in people with epilepsy, particularly in children who are under the supervision of a pediatric dietician and have drug-resistant epilepsy. The specific carbohydrate and paleo diets are popular new diet trends that GPs may encounter, both of which significantly limit carbohydrate intake in the diet.

Managing irritable bowel syndrome (IBS) can be challenging and varies from patient to patient. The National Institute for Health and Care Excellence (NICE) updated its guidelines in 2015 to provide recommendations for the management of IBS. The first-line pharmacological treatment depends on the predominant symptom, with antispasmodic agents recommended for pain, laxatives (excluding lactulose) for constipation, and loperamide for diarrhea. If conventional laxatives are not effective for constipation, linaclotide may be considered. Low-dose tricyclic antidepressants are the second-line pharmacological treatment of choice. For patients who do not respond to pharmacological treatments, psychological interventions such as cognitive behavioral therapy, hypnotherapy, or psychological therapy may be considered. Complementary and alternative medicines such as acupuncture or reflexology are not recommended. General dietary advice includes having regular meals, drinking at least 8 cups of fluid per day, limiting tea and coffee to 3 cups per day, reducing alcohol and fizzy drink intake, limiting high-fiber and resistant starch foods, and increasing intake of oats and linseeds for wind and bloating.

Hospitalization and IV corticosteroids are necessary for the treatment of a severe flare of ulcerative colitis, as seen in this patient with over 6 bloody stools per day and systemic symptoms like tachycardia and fever. Mild to moderate cases can be managed with aminosalicylates and oral steroids. Simple analgesia, increased fluid intake, and oral antibiotics are not effective in managing severe flares of ulcerative colitis.

Ulcerative colitis can be managed through inducing and maintaining remission. The severity of the condition is classified as mild, moderate, or severe based on the number of stools per day, the amount of blood, and the presence of systemic upset. Treatment for mild-to-moderate cases of proctitis involves using topical aminosalicylate, while proctosigmoiditis and left-sided ulcerative colitis may require a combination of oral and topical medications. Severe cases should be treated in a hospital setting with intravenous steroids or ciclosporin.

To maintain remission, patients with proctitis and proctosigmoiditis may use topical aminosalicylate alone or in combination with an oral aminosalicylate. Those with left-sided and extensive ulcerative colitis may require a low maintenance dose of an oral aminosalicylate. Patients who have experienced severe relapses or multiple exacerbations may benefit from oral azathioprine or mercaptopurine. Methotrexate is not recommended for UC management, but probiotics may help prevent relapse in mild to moderate cases.

In summary, the management of ulcerative colitis involves a combination of inducing and maintaining remission. Treatment options vary depending on the severity and location of the condition, with mild-to-moderate cases typically treated with topical aminosalicylate and severe cases requiring hospitalization and intravenous medication. Maintaining remission may involve using a combination of oral and topical medications or a low maintenance dose of an oral aminosalicylate. While methotrexate is not recommended, probiotics may be helpful in preventing relapse in mild to moderate cases.

NICE Guidelines for Referral of Suspected Colorectal Cancer

According to the National Institute for Health and Care Excellence (NICE) guidelines, individuals under the age of 50 who experience a change in bowel habit to looser and/or more frequent stools, along with rectal bleeding, should be urgently referred for suspected colorectal cancer.

In addition, NICE recommends considering a suspected cancer pathway referral for adults under 50 with rectal bleeding and unexplained symptoms such as abdominal pain, weight loss, and iron-deficiency anemia. These referrals should result in an appointment within two weeks to ensure prompt diagnosis and treatment.

It is important to follow these guidelines to ensure early detection and treatment of colorectal cancer, which can significantly improve outcomes for patients.

Consideration of Ovarian Cancer in New Onset IBS after 50

This patient presenting with new onset IBS after the age of 50 should prompt consideration of ovarian cancer. According to NICE guidelines, symptoms such as bloating, early satiety, pelvic/abdominal pain, and urinary frequency/urgency should raise suspicion of ovarian cancer. CA 125 is the test of choice if ovarian cancer is being considered.

Risk factors for ovarian cancer include nulliparity and late menopause. Symptoms that should raise suspicion of ovarian cancer include progressive bloating, early satiety, and urinary frequency. A vaginal examination should be performed if ovarian cancer is suspected since abdominal examination alone can miss an ovarian mass. The family history of psoriasis is not relevant in this case.

Prescribing Colpermin is not necessarily incorrect, but IBS is a diagnosis of exclusion that should be given once serious and common alternatives have been ruled out. Prescribing an antibiotic is inappropriate because there is no evidence of infection here.

An abdominopelvic scan would be an alternative to arranging CA 125, but an abdominal scan by itself is usually not sufficient to fully examine the ovaries. If a CA 125 was high, an ultrasound scan would be arranged to assess the ovaries in more detail, and the results of the two would be combined in an RMI score to assess the risk of malignancy.

In summary, it is important to consider ovarian cancer in cases of new onset IBS after 50, especially if symptoms such as bloating, early satiety, pelvic/abdominal pain, and urinary frequency/urgency are present. A thorough examination and appropriate tests should be performed to rule out this serious condition.

To undergo a urea breath test, one must not have taken antibiotics within the last four weeks and must not have taken any antisecretory drugs, such as PPI, within the last two weeks.

Tests for Helicobacter pylori

There are several tests available to diagnose Helicobacter pylori infection. One of the most common tests is the urea breath test, where patients consume a drink containing carbon isotope 13 enriched urea. The urea is broken down by H. pylori urease, and after 30 minutes, the patient exhales into a glass tube. Mass spectrometry analysis calculates the amount of 13C CO2, which determines the presence of H. pylori. However, this test should not be performed within four weeks of treatment with an antibacterial or within two weeks of an antisecretory drug.

Another test is the rapid urease test, also known as the CLO test. This test involves mixing a biopsy sample with urea and pH indicator, and a color change indicates H. pylori urease activity. Serum antibody tests remain positive even after eradication, and the sensitivity and specificity are 85% and 80%, respectively. Culture of gastric biopsy provides information on antibiotic sensitivity, with a sensitivity of 70% and specificity of 100%. Gastric biopsy with histological evaluation alone has a sensitivity and specificity of 95-99%. Lastly, the stool antigen test has a sensitivity of 90% and specificity of 95%.